Publisher
Springer Science and Business Media LLC
Subject
Radiology, Nuclear Medicine and imaging
Reference29 articles.
1. Bormans G, Buck A, Chiti A, Cooper M, Croasdale J, Desert M, Kumar V, Liu Y, Penuelas I, Rosetti C, Shiavo R, Schwarz SW, Windhorst AD (2017) Position statement on radiopharmaceutical production for clinical trials. EJNMMI Radiopharm Chem 2:12. https://doi.org/10.1186/s41181-017-0031-y
2. Gillings N, Hjelsteun O, Behe M, Decristoforo C, Elsinga PH, Ferrari V, Kiss OC, Kolenc P, Koziorowski J, Laverman P, Mindt TL, Ocak M, Patt M, Todde S, Walte A (2022) EANM guideline on quality risk management for radiopharmaceuticals. EJNMMI 49:3353–3364. https://doi.org/10.1007/s00259-022-05738-4
3. Elsinga PH, Lappchen T, Laverman P, Windhorst AD, Wolterbeek B (2014) A new profession: clinical radiochemist. Towards excellence in nuclear medicine. Tijdschr Nucl Geneesk 36(1):1200–1201
4. Duatti A, Bhonsle U (2013) Strengthening radiopharmacy practice in IAEA member states. Semin Nucl med 43:188–194. https://doi.org/10.1053/j.semnuclmed.2012.11.009
5. Cutler CS, Bailey E, Kumar V, Schwarz SW, Bom HS, Hatazawa J, Paez D, Orellana P, Louw L, Mut F, Kato H, Chiti A, Frangos S, Fahey F, Dillehay G, Oh SJ, Lee DS, Lee ST, Nunez-Millar R, Bandhopadhyay G, Pradhan PK, Scott AM (2021) Global issues of radiopharmaceutical access and availability: a nuclear medicine global initiative project. J Nucl Med 62(3):422–430. https://doi.org/10.2967/jnumed.120.247197